JPH0226496B2 - - Google Patents
Info
- Publication number
- JPH0226496B2 JPH0226496B2 JP59271173A JP27117384A JPH0226496B2 JP H0226496 B2 JPH0226496 B2 JP H0226496B2 JP 59271173 A JP59271173 A JP 59271173A JP 27117384 A JP27117384 A JP 27117384A JP H0226496 B2 JPH0226496 B2 JP H0226496B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- skin
- composition
- probe
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Ultra Sonic Daignosis Equipment (AREA)
Description
(発明の分野)
本発明は、超音波診断装置を用いる際に、超音
波エネルギーの伝播を良好にする目的で、皮膚と
超音波診断用探触子(以下、プローブと略称す
る)との間に塗布して介在させる超音波診断用透
明粘性組成物に関する。
(従来技術)
従来の超音波診断用組成物は、ペースト状組成
物では長時間皮膚と接触していると皮膚温により
流動したり、発汗により組成物に塩析現象が生じ
て液状に変化し、組成物がプローブと皮膚との間
に定留し難く、すき間が出来て空気層が介在し易
くなり、超音波エネルギーの伝播を不良とするこ
とが多い。
また、高粘稠性ゲル状物であつては、皮膚及び
プローブへの密着性はよいが、製造時或いは塗布
時に混入した気泡が抜け難く、同様に空気層(気
泡)が介在することが避けられず、超音波エネル
ギーの伝播を不良とする結果、正確な診断情報を
再現性よく得ることが不可能となる等の欠点を有
していた。
更には、前記高粘稠性のゲル状物はベトツキが
著しく、使用に不便であり、被診断者に不快感を
与えると共に使用後の除去も困難なものであつ
た。
(発明の目的)
本発明は、上記の欠点を悉く改良したものであ
つて、その目的とするところは、プローブと皮膚
との間に定留し、適度な密着性を有し、超音波エ
ネルギーの伝播を良好ならしめ、体温や発汗にも
安定で粘性を与えることなく、長時間にわたつて
水分を保持して空気層の介在を防止し、皮膚刺激
が無く、使用後の除去も容易で、保存安定性にも
優れた超音波診断用透明粘性組成物を提供するに
ある。
(発明の構成)
即ち、本発明の超音波診断用透明粘性組成物
は、カルボキシビニルポリマーの塩とヒドロキシ
エチルセルロースと燐酸二ナトリウムと燐酸一カ
リウムと多価アルコールと水とを配合してなるこ
とを特徴とするものである。
(発明の具体的な構成の説明)
本発明に使用するカルボキシビニルポリマーの
塩は、遊離酸型のカルボキシビニルポリマー(例
えば、米国グツドリツチ社製のカーボポール940
など)と苛性ソーダ、苛性カリ、アルカノールア
ミンなどの塩基性物質との中和塩である。好まし
い、塩基性物質は苛性ソーダ、或いは苛性カルで
ある。カルボキシビニルポリマーの塩の水溶液の
PH値は5〜8である。
カルボキシビニルポリマーの塩の配合量は、組
成物全量を基準として0.4〜1.2重量%、好ましく
は0.5〜1.0重量%である。0.4重量%よりも少なく
なると液状物となり(目的とする粘性物を形成せ
ず)、流動して皮膚とプローブの間に定留させる
ことが難しく、空気層が介在し易い。1.2重量%
よりも多くなると高粘度となり、人体の表面の平
面又は湾曲部など任意の部位にすき間なく密着さ
せることが難しく、使用後の除去も極めて難しく
なる。
ヒドロキシエチルセルロースは、例えば米国ユ
ニオンカーバイド社製のセロサイズWP−
4400M、フジケミカル社製のA5000Fなどであれ
ばよく、粘度が4000〜6000CPS(ブルツクフイー
ルド回転粘度計、測定温度25℃、2重量%水溶
液)のものが好適である。
ヒドロキシエチルセルロースは、上記のカルボ
キシビニルポリマーが呈する特有のゲル状(プリ
ン状)の粘性を本発明の目的に適合するよう改善
する為に配合したものであつて、本発明の組成物
が透明度を保持し、プローブと皮膚の間に塗布し
て、適度な伸展性(流動性)を有すると共に、プ
ローブと皮膚の間に介在して持続的な密着性をも
保有する効果を発揮するものである。更には、ヒ
ドロキシエチルセルロースは、非イオン性であ
り、塩類に対して非常に安定であると共に耐酸
性、耐アルカリ性にも優れている。他のカルボキ
メチルセルロースがアルギン酸ソーダの如くゲル
化(プリン状)を起すことなく、腐敗し難い性質
を有している。
ヒドロキシエチルセルロースの配合量は0.08〜
0.8重量%、好ましくは0.05〜0.6重量%である。
0.03重量%より少ないときには上記の効果を発揮
できず、0.8重量%よりも多くなると組成物の透
明度が低下し、高粘度となり適度な伸展性(伸
び)を得ることができない。
燐酸二ナトリウムと燐酸一カリウムは、その配
合割合が1対0.2〜6.0で、両者の全配合量が0.2〜
2.5重量%(好ましくは0.4〜2.0重量%)配合され
る。上記の最低限界量よりも少なくなると、PHの
緩衝効果が低下して、組成物の保存安定性がわる
くなり易い。また最高限界量よりも多くなると、
塩析現象が発現して、不透明化や水分離を引き起
こし、保存安定性等もわるくなり易い。
多価アルコールは、グリセリン、ジグリセリ
ン、プロピレングリコール、ジプロピレングリコ
ール、1.3−ブチレングリコール、ポリエチレン
グリコールからなる群から選択された少なくとも
一種であればよく、その配合量は組成物全量に対
して10〜80重量%である。多価アルコールの種類
は特に限定されるものではないが、特に好ましく
は、グリセリンとプロピレングリコールを1対
0.5〜1.5の割合で両者の全配合量が18〜25重量%
で配合される。多価アルコールの配合量は10重量
%より少なくなると、組成物が乾燥し易く、プロ
ーブと皮膚との密着性が低減し、超音波エネルギ
ーの伝播が減衰するおそれが有り、80重量%より
も多くなると透明度が低下し、保存安定性もわる
くなる。
水の配合量は組成物全量に対して60〜85重量
%、好ましくは、65〜80重量%であり、60重量%
よりも少なくても、また85重量%を超えても本発
明の目的を達成する組成物を得ることは難しい。
組成物の粘度は2万〜25万CPS(実施例に記載の
方法で測定)に調整することが好ましい。
以下、本発明を実施例にて説明する。
実施例に記載の(1)外観、(2)保存安定性、(3)粘
度、(4)実用特性試験〔耐乾燥性(保水性)及び
耐発汗性、密着性、超音波エネルギー伝播の
減衰、皮膚刺激〕は下記の方法で調べた。
(1) 外観
試料の温度が10〜45℃で透明なものを透明と
した。
(2) 保存安定性
試料を2週間毎に温度が−10℃と45℃に繰り
返し変化する恒温室に3ヶ月保存した後、外観
が透明で水の分離が無いものを安定とし、その
他を不安定とした。
(3) 粘度
試料の温度を30℃とし、ブルツクフイールド
型粘度計(精機工業研究所製ビスメトロンUS
−Al型、ローターNo.4、回転数8r・p・m)
で測定し、単位をセンチポイズ(CPS)で示し
た。
(4) 実用特性
各試料毎に20人の被試験者にて、プローブと
皮膚の間に試料を介在せしめて、密着して15分
間に亘る超音波診断の実用特性試験を実施し
て、下期の項目に関して調査した。
耐乾燥性(保水性)及び耐発汗性
測定時間内に、試料の一部が流動するか、
乾燥して空気層が生じた人の数で示した。
密着性
プローブと皮膚の接触面が傾斜(80℃)し
ている状態で、介在する試料が流動して空気
層が生じた人の数で示した。
超音波エネルギー伝播の減衰
試料に気泡が混入していたか、または測定
時間内に、試料が流動するか、或いは乾燥し
て、テレビに表示される画像の鮮明度が低下
するなどの変化が生じた人の数で示した。
皮膚刺激
測定時に皮膚に刺激を感ぜられたり、測定
終了後、試料を除いた後の皮膚に赤斑、浮腫
などの皮膚刺激を生じた人の数で示した。
実施例1〜8、比較例1〜8
(1) 組成
(Field of the Invention) The present invention aims to improve the propagation of ultrasound energy between the skin and an ultrasound diagnostic probe (hereinafter abbreviated as a probe) when using an ultrasound diagnostic device. The present invention relates to a transparent viscous composition for ultrasonic diagnosis that is applied to and interposed in the skin. (Prior Art) Conventional ultrasonic diagnostic compositions, in the form of pastes, tend to flow due to skin temperature when they are in contact with the skin for a long period of time, and salting out occurs in the composition due to sweating, causing the composition to turn into a liquid. In many cases, the composition is difficult to stay fixed between the probe and the skin, and a gap is formed, which tends to create an air layer, which often impairs the propagation of ultrasonic energy. In addition, highly viscous gel-like materials have good adhesion to the skin and probe, but air bubbles that are mixed in during manufacturing or application are difficult to remove, and air layers (bubbles) may also be present. This method has disadvantages such as making it impossible to obtain accurate diagnostic information with good reproducibility as a result of poor propagation of ultrasonic energy. Furthermore, the highly viscous gel-like material is extremely sticky, making it inconvenient to use, causing discomfort to the patient, and making it difficult to remove after use. (Objective of the Invention) The present invention improves all the above-mentioned drawbacks, and aims to fix the probe and the skin, have appropriate adhesion, and provide ultrasonic energy to the skin. It is stable against body temperature and perspiration, retains moisture for a long time without creating viscosity, prevents the formation of air spaces, does not cause skin irritation, and is easy to remove after use. The object of the present invention is to provide a transparent viscous composition for ultrasonic diagnosis that has excellent storage stability. (Structure of the Invention) That is, the transparent viscous composition for ultrasound diagnosis of the present invention is made by blending a carboxyvinyl polymer salt, hydroxyethyl cellulose, disodium phosphate, monopotassium phosphate, polyhydric alcohol, and water. This is a characteristic feature. (Description of the specific structure of the invention) The carboxyvinyl polymer salt used in the present invention is a free acid type carboxyvinyl polymer (for example, Carbopol 940 manufactured by Gudrich Co., Ltd. in the United States).
etc.) and a basic substance such as caustic soda, caustic potash, or alkanolamine. The preferred basic substance is caustic soda or caustic cal. of aqueous solutions of carboxyvinyl polymer salts
PH value is 5-8. The amount of the salt of the carboxyvinyl polymer is 0.4 to 1.2% by weight, preferably 0.5 to 1.0% by weight, based on the total amount of the composition. If it is less than 0.4% by weight, it becomes a liquid (does not form the desired viscous substance), and it is difficult to flow and stay fixed between the skin and the probe, and an air layer is likely to be formed. 1.2% by weight
If the amount exceeds 1, the viscosity becomes high, making it difficult to adhere to any part of the human body such as a flat or curved surface without gaps, and also extremely difficult to remove after use. Hydroxyethyl cellulose is, for example, Cellosize WP- manufactured by Union Carbide Company, USA.
4400M, A5000F manufactured by Fuji Chemical Co., etc. are sufficient, and those having a viscosity of 4000 to 6000 CPS (Bruckfield rotational viscometer, measurement temperature 25° C., 2% aqueous solution by weight) are suitable. Hydroxyethylcellulose is blended in order to improve the unique gel-like (pudding-like) viscosity exhibited by the above-mentioned carboxyvinyl polymer so as to meet the purpose of the present invention, and the composition of the present invention maintains transparency. However, when applied between the probe and the skin, it has an appropriate extensibility (fluidity) and is interposed between the probe and the skin to exhibit the effect of maintaining continuous adhesion. Furthermore, hydroxyethyl cellulose is non-ionic, extremely stable against salts, and has excellent acid resistance and alkali resistance. Unlike other carboxymethyl celluloses, it does not gel (purine-like) like sodium alginate and has the property of being resistant to spoilage. The blending amount of hydroxyethylcellulose is 0.08~
0.8% by weight, preferably 0.05-0.6% by weight.
If it is less than 0.03% by weight, the above effects cannot be achieved, and if it is more than 0.8% by weight, the composition will decrease in transparency and become highly viscous, making it impossible to obtain appropriate extensibility (elongation). The mixing ratio of disodium phosphate and monopotassium phosphate is 1:0.2 to 6.0, and the total amount of both is 0.2 to 6.0.
It is blended in an amount of 2.5% by weight (preferably 0.4 to 2.0% by weight). When the amount is less than the above minimum limit, the pH buffering effect is reduced and the storage stability of the composition is likely to deteriorate. Also, if the amount exceeds the maximum limit,
A salting-out phenomenon occurs, causing opacity and water separation, and storage stability is likely to deteriorate. The polyhydric alcohol may be at least one type selected from the group consisting of glycerin, diglycerin, propylene glycol, dipropylene glycol, 1.3-butylene glycol, and polyethylene glycol, and its blending amount is 10 to 10% based on the total amount of the composition. It is 80% by weight. The type of polyhydric alcohol is not particularly limited, but particularly preferably one pair of glycerin and propylene glycol is used.
The total amount of both is 18-25% by weight with a ratio of 0.5-1.5
It is blended with. When the amount of polyhydric alcohol is less than 10% by weight, the composition tends to dry, the adhesion between the probe and the skin is reduced, and the propagation of ultrasound energy may be attenuated. If this happens, the transparency will decrease and the storage stability will also deteriorate. The amount of water blended is 60 to 85% by weight, preferably 65 to 80% by weight, and 60% by weight based on the total amount of the composition.
It is difficult to obtain a composition that achieves the object of the present invention even with less than 85% by weight or even with more than 85% by weight.
The viscosity of the composition is preferably adjusted to 20,000 to 250,000 CPS (measured by the method described in Examples). The present invention will be explained below with reference to Examples. (1) Appearance, (2) Storage stability, (3) Viscosity, (4) Practical property tests (drying resistance (water retention), sweating resistance, adhesion, attenuation of ultrasonic energy propagation) described in Examples , skin irritation] was investigated using the following method. (1) Appearance A sample that was transparent at a temperature of 10 to 45°C was considered transparent. (2) Storage stability After storing the samples for 3 months in a constant temperature room where the temperature is changed repeatedly between -10℃ and 45℃ every 2 weeks, those with a transparent appearance and no separation of water are considered stable, and the others are considered unstable. Stable. (3) Viscosity The temperature of the sample was set to 30℃, and a Burckfield viscometer (Bismetron US manufactured by Seiki Kogyo Kenkyusho) was used.
-Al type, rotor No. 4, rotation speed 8r・p・m)
The unit was measured in centipoise (CPS). (4) Practical characteristics A practical characteristics test for ultrasound diagnosis was conducted on 20 test subjects for each sample, with the sample interposed between the probe and the skin for 15 minutes in close contact. We investigated the following items. Drying resistance (water retention) and sweat resistance: Does part of the sample flow during the measurement time?
It is expressed as the number of people who experienced dry air. Adhesion is indicated by the number of people in whom an air space was created due to the intervening sample flowing when the contact surface between the probe and the skin was inclined (80°C). Attenuation of ultrasound energy propagation: There were air bubbles in the sample, or the sample moved or dried during the measurement period, reducing the clarity of the image displayed on the TV. Shown in number of people. Skin irritation The number of people who felt irritation on their skin during the measurement, or who had skin irritation such as red spots or edema on their skin after the measurement was completed and the sample was removed. Examples 1 to 8, Comparative Examples 1 to 8 (1) Composition
【表】
(2) 調整方法
プロピレングリコールとグリセリンの混合液
にカーボポール940を分散したものを残量とす
る水中に分散した後、予め用意したセロサイズ
WP−4400Mの水溶液を注入して攪拌混合す
る。次に苛性ソーダの水溶液を注入し均一に攪
拌混合してカーボポール940を苛性ソーダで中
和した中和塩を生成せしめる。引続いて、リン
酸二ナトリウムとリン酸一カリウム、メチルパ
ラベン及び青色1号の各々水溶液を注入して全
量を均一に攪拌混合せしめて調整する。
(3) 特性
第1表に記載する如く、比較例1の組成物
は、ゲル状(プリン状)を呈し、実用特性に於
いて実用性に乏しいものであつたが、実施例1
の如く、ヒドロキシエチルセルロースを添加す
ることにより改良され、20人の被試験者中2人
にやや難点が見受けられたが特に実用上に問題
は無かつた。また、比較例2は高粘度となり、
気泡が混入すると抜け難く良い結果を得ること
はできなかつた。
実施例4〜5、比較例4〜7
(1) 組成[Table] (2) Preparation method After dispersing Carbopol 940 in a mixture of propylene glycol and glycerin in the remaining amount of water, add the cello size prepared in advance.
Inject the aqueous solution of WP-4400M and stir to mix. Next, an aqueous solution of caustic soda is injected and stirred and mixed uniformly to generate a neutralized salt in which Carbopol 940 is neutralized with caustic soda. Subsequently, aqueous solutions of disodium phosphate, monopotassium phosphate, methylparaben, and Blue No. 1 were injected, and the total amount was uniformly stirred and mixed for adjustment. (3) Characteristics As shown in Table 1, the composition of Comparative Example 1 was gel-like (pudding-like) and had poor practical properties.
This was improved by adding hydroxyethyl cellulose, and although 2 out of 20 test subjects found it somewhat difficult, there were no problems in practical use. In addition, Comparative Example 2 had a high viscosity,
If air bubbles were mixed in, it was difficult to remove them and good results could not be obtained. Examples 4-5, Comparative Examples 4-7 (1) Composition
【表】
注) * 但し苛性カリは実施例1の苛性ソー
ダと同様である。
(2) 調整方法
実施例1の調整方法と同様にして調整する。
(3) 特性
第1表に記載の如く、実施例4はやや乾燥し
易く2人にやや難点が見られたが、実用上にほ
とんど問題点は見られなかつた。また、実施例
5は1人のみに軽度の紅斑が見られたが充分に
実用出来る程度のものであつた。
比較例は燐酸の塩類が少なく耐発汗性に欠点
が見られ、比較例5は逆に塩類が多く組成物の
透明度と粘度が低下し、密着性に乏しく、比較
例6は多価アルコールの配合量が少なく耐乾燥
性に難点を有し、比較例7は逆に多価アルコー
ルの配合量が過剰となり皮膚刺激が見られた。[Table] Note) * However, the caustic potash is the same as the caustic soda in Example 1.
(2) Adjustment method Adjustment is performed in the same manner as in Example 1. (3) Characteristics As shown in Table 1, Example 4 was a little dry, which caused some difficulty for two people, but practically no problems were observed. Furthermore, in Example 5, mild erythema was observed in only one patient, but the level was sufficient for practical use. Comparative Example contains less phosphoric acid salts and has disadvantages in sweat resistance, Comparative Example 5 contains more salts and the transparency and viscosity of the composition decreases, resulting in poor adhesion, and Comparative Example 6 contains polyhydric alcohol. The amount of polyhydric alcohol was small and the drying resistance was poor, whereas in Comparative Example 7, the amount of polyhydric alcohol blended was excessive and skin irritation was observed.
【表】【table】
【表】
(発明の効果)
以上、記載の如く本発明は超音波診断装置に適
用して従来の欠点を悉く改善した超音波診断用透
明粘性組成物を提供することは明らかである。即
ち、本発明の組成物は、透明な組成物で適度な粘
性を有することにより気泡の混入を防ぎ、プロー
ブ及び皮膚への塗布を容易にして、プローブと皮
膚との間に持続的に密着し、超音波エネルギーの
伝播を良好に保持する効果を有する。また、保存
安定性も良好で皮膚刺激も無く優れた超音波診断
用透明粘性組成物である。[Table] (Effects of the Invention) As described above, it is clear that the present invention provides a transparent viscous composition for ultrasonic diagnosis which can be applied to ultrasonic diagnostic equipment and has improved all the conventional drawbacks. That is, the composition of the present invention is a transparent composition and has an appropriate viscosity, thereby preventing air bubbles from being mixed in, making it easy to apply to the probe and the skin, and maintaining continuous close contact between the probe and the skin. , has the effect of maintaining the propagation of ultrasonic energy well. In addition, it is an excellent transparent viscous composition for ultrasonic diagnosis with good storage stability and no skin irritation.
Claims (1)
断用透明粘性組成物。 (A) カルボキシビニルポリマーの塩;0.4〜1.2重
量% (B) ヒドロキシエチルセルロース;0.03〜0.8重
量% (C) 多価アルコール;10〜30重量% (D) 燐酸二ナトリウムと燐酸一カリウム(重量比
1対0.2〜6.0);0.2〜2.5重量% (E) 水[Scope of Claims] 1. A transparent viscous composition for ultrasound diagnosis, comprising the following components (A) to (E). (A) Salt of carboxyvinyl polymer; 0.4-1.2% by weight (B) Hydroxyethyl cellulose; 0.03-0.8% by weight (C) Polyhydric alcohol; 10-30% by weight (D) Disodium phosphate and monopotassium phosphate (weight ratio 1:0.2-6.0); 0.2-2.5% by weight (E) Water
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27117384A JPS61149128A (en) | 1984-12-21 | 1984-12-21 | Transparent viscous composition for ultrasonic diagnosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27117384A JPS61149128A (en) | 1984-12-21 | 1984-12-21 | Transparent viscous composition for ultrasonic diagnosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61149128A JPS61149128A (en) | 1986-07-07 |
| JPH0226496B2 true JPH0226496B2 (en) | 1990-06-11 |
Family
ID=17496356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27117384A Granted JPS61149128A (en) | 1984-12-21 | 1984-12-21 | Transparent viscous composition for ultrasonic diagnosis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61149128A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0770072B2 (en) * | 1987-12-29 | 1995-07-31 | 三菱電機株式会社 | Optical information recording / reproducing device |
| JPH0651036B2 (en) * | 1989-03-15 | 1994-07-06 | 富士写真光機株式会社 | Ultrasonic diagnostic equipment |
| EP1506022A2 (en) | 2002-05-09 | 2005-02-16 | Ultrast LLC | Medium for contrast enhancement use for ultrasonic, endoscopic, and other medical examinations |
| US7575552B2 (en) * | 2004-06-10 | 2009-08-18 | Panasonic Corporation | Ultrasonic probe with acoustic medium |
| JP5576165B2 (en) * | 2010-03-31 | 2014-08-20 | 株式会社ノエビア | Gel composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5563636A (en) * | 1978-11-06 | 1980-05-13 | Koyo Sangyo Co | High molecular gel containing water for ultrasoniccwave diagnosis |
| JPS5949750A (en) * | 1982-09-13 | 1984-03-22 | 株式会社クラレ | Contact medium of ultrasonic diagnostic probe |
| JPS5982838A (en) * | 1982-11-04 | 1984-05-14 | 株式会社クラレ | Contact medium of probe for utrasonic tomographic apparatus |
| JPS60225544A (en) * | 1984-04-23 | 1985-11-09 | 東レ株式会社 | Coupler for high frequency ultrasonic transducer |
| JPS61146234A (en) * | 1984-12-20 | 1986-07-03 | ダイセル化学工業株式会社 | Catalytic substance for ultrasonic diagnosis |
-
1984
- 1984-12-21 JP JP27117384A patent/JPS61149128A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61149128A (en) | 1986-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4518721A (en) | Hydrophilic denture adhesive | |
| JPS628412B2 (en) | ||
| SE466134B (en) | GEL-PHARMACEUTICAL LIQUID COMPOSITION AND APPLICATION THEREOF IN PHARMACEUTICAL COMPOSITIONS | |
| CN1151770C (en) | Non-sticky gel toothpaste containing kappa carrageenan and cellulose as binders | |
| JPS61180705A (en) | Cosmetic | |
| JPH0226496B2 (en) | ||
| JP6260111B2 (en) | Anti-wrinkle composition and cosmetic | |
| JPS6239507A (en) | Cosmetic for keeping skin in good state | |
| EP0113079A2 (en) | Karaya gum adhesive in a hydrophilic denture vehicle | |
| JPS6075405A (en) | Powdery solid cosmetic | |
| JPS6137710A (en) | Emulsified composition | |
| JPH0424024A (en) | Transparent viscous composition for ultrasonic diagnosis | |
| JP2004168725A (en) | External aqueous composition for skin | |
| JPS5832810A (en) | Film-type pack | |
| JPS62238216A (en) | Steroid cream preparation | |
| JPS60115507A (en) | Cosmetic pack | |
| EP0064672B1 (en) | Denture adhesive composition | |
| JPH0239550B2 (en) | ||
| JPS6067404A (en) | Coating film type pack material | |
| JP4251737B2 (en) | Gel emulsion composition for external use | |
| CN121196927A (en) | A water-in-oil makeup primer and its preparation method | |
| JPS63104914A (en) | Skin preparation | |
| KR0180118B1 (en) | Aminoacid-contained lipohumor gel and cosmetic composition | |
| CN115429714A (en) | Mask material composition and mask | |
| JPH08175931A (en) | Endothermic pack cosmetic |